Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-01 Sale | 2025-12-03 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 191,854 | $5.9826 | $1,147,786 | 13,728,924 (Indirect) | View |
| 2025-12-01 Sale | 2025-12-02 7:48 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $6.0032 | $132,070 | 1,188,391 (Direct) | View |
| 2025-11-26 Sale | 2025-12-01 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 189,431 | $6.4069 | $1,213,667 | 13,920,778 (Indirect) | View |
| 2025-11-24 Sale | 2025-11-26 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 463,774 | $6.2666 | $2,906,278 | 14,110,209 (Indirect) | View |
| 2025-11-17 Sale | 2025-11-18 2:47 pm | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 6,799 | $5.557 | $37,782 | 110,701 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 3:27 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP, General Counsel, Corp Sec | 2,385 | $5.16 | $12,307 | 78,210 (Direct) | View |
| 2025-11-03 Sale | 2025-11-04 7:40 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 1,365 | $5.863 | $8,003 | 80,595 (Direct) | View |
| 2025-11-03 Sale | 2025-11-04 11:58 am | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $5.6385 | $124,047 | 1,210,391 (Direct) | View |
| 2025-10-28 Sale | 2025-10-30 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 24,553 | $6.5024 | $159,655 | 14,573,983 (Indirect) | View |
| 2025-10-24 Sale | 2025-10-28 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 113,099 | $6.0113 | $679,870 | 14,598,536 (Indirect) | View |
| 2025-10-22 Sale | 2025-10-24 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 298,649 | $6.0686 | $1,812,378 | 14,711,635 (Indirect) | View |
| 2025-10-20 Sale | 2025-10-22 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 330,210 | $6.2331 | $2,058,247 | 15,010,284 (Indirect) | View |
| 2025-10-15 Sale | 2025-10-17 4:15 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 29,515 | $6.0838 | $179,563 | 15,340,494 (Indirect) | View |
| 2025-10-09 Sale | 2025-10-14 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 251,360 | $6.1422 | $1,543,899 | 15,370,009 (Indirect) | View |
| 2025-10-07 Sale | 2025-10-09 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 538,375 | $5.9883 | $3,223,939 | 15,621,369 (Indirect) | View |
| 2025-10-03 Sale | 2025-10-07 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 524,297 | $5.574 | $2,922,426 | 16,159,744 (Indirect) | View |
| 2025-10-01 Sale | 2025-10-02 11:53 am | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $5.8362 | $128,396 | 1,232,391 (Direct) | View |
| 2025-09-02 Sale | 2025-09-03 1:50 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $4.9914 | $109,811 | 1,254,391 (Direct) | View |
| 2025-08-01 Sale | 2025-08-04 12:27 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $4.9863 | $109,699 | 1,276,391 (Direct) | View |
| 2025-07-15 Sale | 2025-07-17 6:46 pm | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 10,382 | $5.4701 | $56,791 | 104,618 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 5:03 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $5.1003 | $112,207 | 1,298,391 (Direct) | View |
| 2025-06-02 Sale | 2025-06-02 7:26 pm | Vir Biotechnology Inc. | VIR | Napolitano Janet Director | 3,200 | $5.0465 | $16,149 | 32,416 (Direct) | View |
| 2025-04-03 Sale | 2025-04-04 4:23 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 79,712 | $5.9494 | $474,239 | 822,623 (Indirect Direct) | View |
| 2025-02-26 Sale | 2025-02-27 12:39 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 7,373 | $9.1418 | $67,402 | 79,460 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:44 pm | Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director | 10,056 | $9.4534 | $95,063 | 3,813,528 (Indirect Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:43 pm | Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer | 14,168 | $9.4534 | $133,936 | 117,901 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:37 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 1,562 | $9.4534 | $14,766 | 86,627 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:36 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 16,122 | $9.4534 | $152,408 | 1,382,335 (Indirect Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:34 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 5,140 | $9.4534 | $48,590 | 156,833 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-09 Other | 2025-06-09 6:39 pm | N/A N/A | Vir Biotechnology Inc. | VIR | MORE ROBERT J Director | 14,027 | $0 | 578,627 (Direct) | View |
| 2025-06-06 Other | 2025-06-06 8:26 pm | N/A N/A | Vir Biotechnology Inc. | VIR | BISCHOFBERGER NORBERT W Director | 10,667 | $0 | 45,334 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:31 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 24,000 | $0 | 57,806 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:28 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 24,000 | $0 | 1,336,391 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:27 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | Ramasastry Saira Director | 24,000 | $0 | 38,619 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:26 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | Napolitano Janet Director | 24,000 | $0 | 32,416 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:22 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | MORE ROBERT J Director | 24,000 | $0 | 566,573 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:20 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | Hatfield Jeffrey S. Director | 24,000 | $0 | 47,806 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:19 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | Farid Ramy Director | 24,000 | $0 | 40,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 7:17 pm | 2026-05-30 2035-05-29 | Vir Biotechnology Inc. | VIR | BISCHOFBERGER NORBERT W Director | 24,000 | $0 | 40,000 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:41 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 120,000 | $0 | 195,000 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:39 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 120,000 | $0 | 195,000 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:37 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 60,000 | $0 | 86,627 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:36 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 720,000 | $0 | 1,382,335 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:34 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 105,000 | $0 | 156,833 (Direct) | View |